News

The passing of the new Drug Administration Law brings the following issues to attention

On August 26, the newly revised Drug Administration Law of the Peoples Republic of China was adopted...

2019.08.27

902
Huapont participate in joint venture to set up innovative drug R&D platform to develop New nano-antibody drugs

On March 20, Huapont Life Sciences Co.,Ltd. revealed that, in order to develop new nano- antibody dr...

2019.07.15

834
In the first half of 2019, 57 Class-I Chinese new drugs filed the Investigational New Drug Application (IND), with CSPC & Chiatai Tianqing as the leading innovators!

In 2018, a record high of over 100 Investigational New Drug Applications were handled by the state d...

2019.07.10

875
Congratulations! Chengdu Advanced Medical Science Center has its first circle of funding friends

On March 28, the 2019 China (Chengdu) Health Care Investment and Development Seminar and the 2018 Ch...

2019.04.04

811
RMB 1 million for Most Talented Individuals: Golden Panda Talent Award in Chengdu High-tech Zone, Hurry Up!

Chengdu High-tech Industrial Development Zone (CDHT) issued in April 2018 the Several Policies of Ch...

2019.03.05

834
First in China: Nahai High-Tech Starts Registering New Generation of Non-Invasive Prenatal Gene Testing Kit

Chengdu Nahai High-Tech Biological Technology Co., Ltd. (Nahai for short), a company based in Tianfu...

2019.02.25

764

4
5
6
7
8

Park WeiChart

工信部备案号：蜀ICP备19016361号版权所有：天府生命科技园中国西部生命科技产业门户技术支持：成都驰创数码